The publisher's Medical Devices sector report, “Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Spinal Cord Stimulators (SCS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is an implantable medical device used to treat chronic pain of neurological origin. An electric impulse generated by the device near the dorsal surface of the spinal cord provides a paresthesia sensation that alters the perception of pain by the patient. One unit consists of one impulse generator, lead, and electrodes.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is an implantable medical device used to treat chronic pain of neurological origin. An electric impulse generated by the device near the dorsal surface of the spinal cord provides a paresthesia sensation that alters the perception of pain by the patient. One unit consists of one impulse generator, lead, and electrodes.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Spinal Cord Stimulators (SCS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Spinal Cord Stimulators (SCS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Spinal Cord Stimulators (SCS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Spinal Cord Stimulators (SCS) - Pipeline Products under Development by Companies
5 Spinal Cord Stimulators (SCS) Companies and Product Overview
6 Spinal Cord Stimulators (SCS)- Recent Developments
7 Appendix
List of Tables
16 Channel Spinal Cord Stimulator - Product Description
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biotronik Inc
- Boston Scientific Corp
- Cerevast Therapeutics Inc
- Direct Spinal Therapeutics, Inc.
- Duke University
- GTX Medical BV
- Imperial College London
- Lawson Health Research Institute
- Meagan Medical Inc.
- Medtronic Plc
- Micro-Leads Inc
- MicroTransponder Inc
- Neuronoff Inc
- NeuroOne Inc
- Nevro Corp
- Nexstim Plc
- Nuvectra Corp
- Onward Technologies Ltd
- Quantum Nanostim LLC
- Saluda Medical Pty Ltd
- Soin Neuroscience Inc
- Soterix Medical Inc
- SpineX
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- St. Jude Medical LLC
- Stimdia Medical Inc
- SynerFuse Inc
- Teliatry Inc
- University of California Los Angeles
- University of Cambridge
- University of Minnesota
- Wavegate Corp
- WISE s.r.l.
